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Abstract
Advance health care directives and informed consent remain the cornerstones of patients' right to
self-determination regarding medical care and preferences at the end-of-life. However, the
effectiveness and clinical applicability of advance health care directives to decision-making on the
use of life support systems at the end-of-life is questionable. The Uniform Anatomical Gift Act
(UAGA) has been revised in 2006 to permit the use of life support systems at or near death for
the purpose of maximizing procurement opportunities of organs medically suitable for
transplantation. Some states have enacted the Revised UAGA (2006) and a few of those have
included amendments while attempting to preserve the uniformity of the revised Act. Other states
have introduced the Revised UAGA (2006) for legislation and remaining states are likely to follow
soon.
The Revised UAGA (2006) poses challenges to the Patient Self Determination Act (PSDA)
embodied in advance health care directives and individual expression about the use of life support
systems at the end-of-life. The challenges are predicated on the UAGA revising the default choice
to presumption of donation intent and the use of life support systems to ensure medical suitability of
organs for transplantation. The default choice trumps the expressed intent in an individual's
advance health care directive to withhold and/or withdraw life support systems at the end-of-life.
The Revised UAGA (2006) overrides advance directives on utilitarian grounds, which is a serious
ethical challenge to society. The subtle progression of the Revised UAGA (2006) towards the
presumption about how to dispose of one's organs at death can pave the way for an affirmative
"duty to donate". There are at least two steps required to resolve these challenges. First, physicians
and hospitals must fulfill their responsibilities to educate patients on the new legislations and
document their preferences about the use of life support systems for organ donation at the end-
of-life. Second, a broad based societal discussion must be initiated to decide if the Revised UAGA
(2006) infringes on the PSDA and the individual's right of autonomy. The discussion should also
address other ethical concerns raised by the Revised UAGA (2006), including the moral stance on
1) the interpretation of the refusal of life support systems as not applicable to organ donation and
2) the disregarding of the diversity of cultural beliefs about end-of-life in a pluralistic society.
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Background
In 1990, the U.S. Congress passed the Patient Self-Deter-
mination Act (PSDA) reinforcing individuals' rights to
determine their final health care. The PSDA became effec-
tive in 1991 so that patients can make decisions about
their medical care and specify whether they want to accept
or refuse specific medical care [1]. Patients' wishes can be
clearly documented at an earlier point of time in advance
health care directives and/or patients can identify legally
authorized representatives to make health care decisions
(power-of-attorney for health care) on their behalf in the
event of an incapacitating illness.
The PSDA requires Medicare and Medicaid providers,
including hospitals, to give adult individuals, at the time
of inpatient admission, certain information about their
rights under state laws governing advance health care
directives, including: (1) the right to participate in and
direct their own health care decisions; (2) the right to
accept or refuse medical or surgical treatment; (3) the
right to prepare advance health care directives and (4)
information on the provider's policies governing the utili-
zation of these rights [2].
Scope of advance health care directives
Almost 16 years later, advance health care directives and
power-of-attorney for health care still play a limited, yet
important, role in assisting with health care decisions
about the use of life support systems and medical technol-
ogies at the end-of-life [3]. About 21% of critically ill
patients admitted to intensive care units for life support
systems at the end-of-life have formal advance health care
directives [4].
Criticisms have been rightfully expressed concerning the
current deficiencies of construction, documentation,
accessibility and applicability of advance health care
directives [5]. The main reasons limiting the applicability
of advance health care directives include: 1) physicians'
uncertainties about diagnosis, treatment efficacy, and
prognosis and 2) lack of knowledge, insight, and courage
of persons authorized as power-of-attorney for health care
to fulfill their assigned roles. These shortfalls raise con-
cerns about the effectiveness of advance health care direc-
tives to prepare patients and families for uncertain and
difficult decisions at the end-of-life [6]. To accommodate
these concerns, advance care planning should be built on
effective communication to individualize medical care
and decision making despite future uncertainties.
Advance care planning requires physicians to take time to
discuss advance health care directives with patients and
identify the specific circumstances in which care prefer-
ences should be followed [5].
Considering the above shortfalls, this commentary high-
lights additional and unique challenges posed by the
Revised Uniform Anatomical Gift Act (UAGA) 2006 on
advance health care planning and directives about the use
of life support systems at the end-of-life [7]. Some states
have already enacted the Revised UAGA (2006) and a few
of those have included amendments while attempting to
preserve the uniformity of the revised Act [8]. Other states
have introduced the Revised UAGA (2006) for legislation
and remaining states are likely to follow soon.
Scope of deceased organ donation
In 2006, the publication of two influential reports from
the Institute of Medicine and National Conference on
Donation After Cardiac Death opened a new era for
deceased organ donation [9,10]. Traditionally, organs for
transplantation have been donated by individuals who
fulfilled strict criteria of neurologic or brain death and had
already been on life support systems [11]. Organ dona-
tion after cardiac death applies to individuals who sustain
death because of circulatory or cardiorespiratory arrest
and without the requirement for antecedent neurologic or
brain death criteria. The two reports conclude that dona-
tion after cardiac death is an ethically acceptable form of
organ donation. As of January 2007, federal regulations
require Medicare-approved hospitals to design policies
and procedures for donation after cardiac death from
patients at or near death [12].
Scope of the Revised UAGA (2006)
The National Conference of Commissioners on Uniform
State Laws (NCCUSL) promulgated the Revised UAGA
(2006) with the substantial and active participation of the
major stakeholders representing donors, recipients, physi-
cians, procurement organizations, regulatory agencies and
the US Department of Health & Human Services. The
stakeholders represented a broad spectrum of organiza-
tions with special interest or advocacy for the practice of
organ transplantation. The primary intent of revising the
UAGA in 2006 was to solve the critical organ shortage by
maximizing the likelihood of organ donation. To accom-
plish this objective, the Revised UAGA (2006) increases
opportunities of organ procurement after cardiac death
for transplantation [7]. The anatomical gifting of organs
(heart, lungs, kidneys, liver, pancreases, small bowel, etc.)
after cardiac death requires the initiation and/or continu-
ation of life support systems at the end-of-life to ensure
their medical suitability for transplantation.
The Revised UAGA (2006) reaffirms that if a donor has a
document of gift, there is no reason to seek consent from
the donor's family as they have no right to give it legally
[7]. If an individual has not made a document of gift dur-
ing life, the Revised UAGA (2006) presumes the intent to
donate organs and, therefore, has expanded the list of per-Philosophy, Ethics, and Humanities in Medicine 2007, 2:19 http://www.peh-med.com/content/2/1/19
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sons (in section 9a) who can consent to organ donation
on behalf of that individual. The Revised UAGA (2006)
considers that every individual has the right to donate his
(her) organs at or near death. Finally, if an individual pre-
fers not to donate, this must be documented in a signed,
explicit refusal.
The Revised UAGA (2006) section 14 was drafted in
accordance with the controlling federal law requiring hos-
pitals to notify an organ procurement organization
(OPO) of any individual whose death is imminent or who
has died in-hospital to increase opportunities of organ
procurement for transplantation [13]. In cases of poten-
tial organ donation, measures necessary to ensure the
medical suitability of an organ for transplantation are
administered to a patient who is dead or near death to
allow time for determination if the patient could be a pro-
spective donor. That provision applies to situations of
sudden in-hospital or out-of-hospital cardiac death when
resuscitation is unsuccessful [9]. Organ preservation
requires the administration of life support systems until
the OPO has determined if a patient can be a prospective
donor. The Revised UAGA (2006), section 14(c), requires
life support systems already administered to a patient who
has been referred to the OPO for evaluation to be contin-
ued until it is determined that the patient has organs that
are medically suitable for transplantation. This section
applies to a patient who is already on life support systems
either in the emergency department or intensive care unit
at the end-of-life.
The Revised UAGA (2006), section 14, emphasizes the
general direction in an advance health care directive or
power-of-attorney for health care that the patient's wish
not to have life prolonged by the administration of life sup-
port systems should not be construed as an expression of
a contrary intent for the use of life support systems for
donation purpose [7]. In effect, a patient on life support
systems at the end-of-life (and without signed refusal) is
defaulted to the presumption of intent to donate organs,
and therefore life support systems cannot be withdrawn
until the OPO's evaluation for organ donation is com-
plete. The OPO can then determine that the patient is a
prospective donor.
If determined to be a prospective donor, the Revised
UAGA (2006), section 21, creates a default rule requiring
that measures necessary to ensure the medical suitability
of an organ for transplantation may not be withheld or
withdrawn. The initiation and/or continuation of life sup-
port systems is the default rule and overrides a prospective
donor's expression in an advance health care directive not
to have life prolonged by life support systems. To resolve
the tension between the presumed intent to donate organs
and the expressed intent not to have life support systems
administered merely to prolong life, section 21 presumes
that for a prospective donor the desire to save lives by
making an anatomical gift trumps the desire to have life
support systems withheld or withdrawn. The Revised
UAGA (2006) requires a prospective donor to expressly
provide contrary intent to prevent the use of life support
systems for organ donation purposes in either a declara-
tion or advance health care directives.
In 2007, an amendment was introduced to the Revised
UAGA (2006), section 21, to recognize the conflict
between initiation and/or continuation of life support
systems based on becoming a prospective donor and the
expressed wishes of appropriate end-of-life care in
advance health care directives. Section 21(b) (2007)
requires the attending physician to resolve the conflict
with the prospective donor or surrogate decision maker
for clarification of intent and any contraindications for
appropriate end-of-life care.
The Revised UAGA (2006) and advance health 
care directives
With the new UAGA legislation, advance health care plan-
ning should include education on the new requirement of
the Revised UAGA (2006) about the use of life support
systems for organ donation at the end-of-life. These
changes are predicated on the UAGA revising the default
choice to presumption of donation intent and, therefore,
the requirement for life support systems to ensure medical
suitability of organs for transplantation. Figure 1 summa-
rizes how document of gift, advance health care directives,
contrary intent declaration and refusal determine the
pathway for withholding and/or withdrawal of life sup-
port systems at the end-of-life. Only a refusal and contrary
intent declaration can permit the withholding and/or
withdrawal of life support systems and the administration
of appropriate end-of-life care as expressed in advance
health care directives (figure 1).
Patients with documents of gift are considered donors
irrespective of advance health care directives and they are
required to comply with organ procurement protocols
(figure 1). In the default pathway, (i.e. the absence of
refusal and contrary intent declaration) life support sys-
tems are required, irrespective of advance health care
directives, until the evaluation of medical suitability of
organs for transplantation has been completed. Regard-
less of whether it is morally right to construe refusal of life
support in an advance directive as not applicable for
organ donation, the final authority of the OPO to deter-
mine donor's medical suitability raises additional norma-
tive ethical issues. Three factors can inflate the pool of
prospective donors unpredictably: 1) the OPO can apply
liberal criteria about medical suitability for donation
because the definition of eligible donors is very broadPhilosophy, Ethics, and Humanities in Medicine 2007, 2:19 http://www.peh-med.com/content/2/1/19
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[12], 2) the OPO has the discretion to offer for transplan-
tation organs of marginal (inferior) quality that would be
otherwise rejected [14], 3) the OPO's decisions and
actions are defaulted to be "in good faith" and are the sub-
ject of immunity from criminal, civil and administrative
liabilities [7]. Specific conditions such as overwhelming
infections, disseminated malignancy and communicable
infectious diseases are absolute exclusion criteria for
organ donation. However, the majority of potential organ
donors are unlikely to meet any of these specific exclusion
criteria [15].
The laxity of criteria of medical suitability for donation is
most disturbing to patients who become prospective
donors without documents of gift and who have unequiv-
ocal advance health care directives expressing intent for
The revised Uniform Anatomical Gift Act (UAGA) 2006, advance health care directives (AD) and use of life support systems at  the end-of-life Figure 1
The revised Uniform Anatomical Gift Act (UAGA) 2006, advance health care directives (AD) and use of life 
support systems at the end-of-life. The UAGA (2006) Section 14(c) defaults a patient already on life support systems to 
the presumption of intent for organ donation (i.e. potential donor) and mandatory notification of organ procurement organiza-
tion for evaluation. Life support systems cannot be withdrawn in a potential donor until organ procurement organization has 
completed the evaluation of medical suitability of organs for transplantation. If the organ procurement organization has deter-
mined that a potential donor has organs medically suitable for transplantation, the potential donor becomes a prospective 
donor. For a prospective donor, life support systems cannot be withheld or withdrawn. For a prospective donor, section 21(b) 
requires the attending physician to resolve the conflict between intent in advance health care directives to withhold and/or 
withdraw life support systems at the end-of-life verus their use for organ donation purpose. Section 9(a) expands the list of 
persons who can consult, on behalf of a prospective donor, with the attending physician to resolve the aforementioned conflict 
and provide donation consent (or refusal). Document of gift or donation consent permits the use of life support systems and 
organ procurement protocols on donors. If a potential donor has medically unsuitable organs, refusal of gift or contrary intent 
declaration to instruct the withholding and/or withdrawing of life support systems for organ donation purpose, life support sys-
tems can be withdrawn and end-of-life care is provided as expressed in advance health care directives.
Patient at the end-of-life 
on life support systems  
AD, Contrary intent declaration and Refusal
Potential donor (organs, tissue and eyes)
Continued life support systems 
UAGA section 14(c)
Prospective donor (organs, tissue and eyes )
Continued life support systems
UAGA section 21(b) 
UAGA  section 9 (a)
Permit withdrawal 
of life support systems 
and end-of-life care  per AD
Donor (organs, tissue and eyes) 
Continued life support systems 






Refusal of donation 
Consent for donation 
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withholding and/or withdrawal of life support systems at
the end-of-life (figure 1). Under such circumstances, the
Revised UAGA (2006) requires the attending physician to
address and resolve the conflict between the use of life
support systems for donation purposes and appropriate
end-of-life care with families and/or surrogate-decision
makers while keeping the patient on life support systems.
The Revised UAGA (2006) and end-of-life care
In the endeavor to solve the critical organ shortage, the
Revised UAGA (2006) has transformed the traditional
'altruistic' to a disturbing 'utilitarian' approach towards
organ procurement for transplantation. National pallia-
tive and hospice care organizations [16,17] promoting
excellence in end-of-life care should have been better rep-
resented as stakeholders when drafting the revised UAGA.
As a consequence, the UAGA drafting committee was able
to set aside the advancements in end-of-life care accom-
plished over the past decade [18,19]. While the drafting
committee has refuted that the Revised UAGA (2006) was
drafted to accomplish the goals of special interest groups
[20], the Act undoubtedly has created unintended conse-
quences jeopardizing the general public's interest and dis-
regarding longstanding respect of individual autonomy
and diversity of cultural beliefs about end-of-life in a plu-
ralistic society. The premises underlying the subtle pro-
gression of the Revised UAGA (2006) towards the
presumption about how to dispose of one's organs at or
near death can pave the way for an affirmative "duty to
donate" to the detriment of human liberty in a free society
[21].
The Revised UAGA (2006) has not adopted presumed
consent for organ procurement. Nevertheless, the most
disturbing consequence of the Act is that patients will be
forced to have life support systems initiated or continued
The enactment status of the United States Revised Uniform Anatomical Gift Act (UAGA) 2006 as of September 2007. Figure 2
The enactment status of the United States Revised Uniform Anatomical Gift Act (UAGA) 2006 as of Septem-
ber 2007. The Revised Uniform Anatomical Gift Act (UAGA) 2006 is enacted in many states and a few of those have included 
amendments (dark shade areas). Other states have introduced the Revised UAGA (2006) for legislation (light shade areas). The 
data source is the National Conference of Commissioners on Uniform State Laws.Philosophy, Ethics, and Humanities in Medicine 2007, 2:19 http://www.peh-med.com/content/2/1/19
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while awaiting the assessment of their organs for dona-
tion. In an epidemiologic study of the use of intensive care
at the end-of-life in the US, one in five Americans die
using intensive care services [15]. It is likely that the
Revised UAGA (2006) will further increase the ratio of
Americans dying in intensive care units by legitimizing
presumed consent for the use of life support systems for
organ donation.
The application of life support systems for the purpose of
organ donation without explicit consent is contraindi-
cated at end-of-life and inconsistent with recommended
practice guidelines for quality palliative care [19,22]. Life
support systems have no palliative benefit and inflict
unwarranted traumatic and distressing experiences to
dying patients and their families [23,24]. While section
21(b) (2007) concedes to the obvious conflict between
Table 1: Glossary of terms
"Advance health care directive" means a power-of-attorney for health care or a record signed or authorized by a prospective donor containing 
the prospective donor's direction concerning a health care decision for the prospective donor.
"Anatomical gift" means a donation of all or part (an organ, an eye, or tissue) of a human body to take effect after the donor's death for the 
purpose of transplantation, therapy, research, or education. "
"Contrary intent" means a document expressing that no measures to be taken to ensure the medical suitability of an organ for transplantation 
and authorize and instruct the withholding and/or withdrawing of such medical measures and treatment including life support systems for that 
purpose.
"Declaration" means a record signed by a prospective donor specifying the circumstances under which life support systems may be withheld or 
withdrawn from the prospective donor.
"Document of gift" means a donor card or other record used to make an anatomical gift. The term includes a statement or symbol on a driver's 
license, identification card, or donor registry.
"Donor" means an individual whose body or part is the subject of an anatomical gift.
"Health care decision" means any decision regarding the health care of the prospective donor.
"Life support systems" means the use of machines and/or administration of medications for artificial support of vitals organs. Mechanical 
ventilators support the respiratory system. Medications and/or mechanical means (e.g. external cardiac compression devices, internal cardiac assist 
devices or artificial heart-lung machines) support the circulatory system.
"Medically suitable organs" means the determination of medical suitability of organs by the organ procurement organization who performs the 
examination and evaluation of potential donors.
"Organ procurement organization" means a private organization operating under government contract to provide services covering all aspects 
of deceased organ donation to include 1) donor evaluation, selection and consenting and 2) preparation, recovery and transportation of procured 
organs. Each organization is assigned to a specific geographic area or donation service area within the US. There are 58 organizations covering all 
states including the District of Columbia, Puerto Rico, the United States Virgin Islands, or any territory or insular possession subject to the 
jurisdiction of the US.
"Organ procurement protocols" means medical treatment and surgical procedures performed on donors to ensure successful procurement of 
viable organs for transplantation.
"Power-of-attorney for health care" means a legally authorized representative to make health care decisions on behalf of an individual in the 
event of an incapacitating illness and inability to make own health care decisions.
"Prospective donor" means an individual who is dead or near death and has been determined to have one or more parts that could be medically 
suitable for transplantation, therapy, research, or education. The term includes an individual who made an anatomical gift during life and, therefore, 
is a donor. The term also includes a non-donor individual at or near the time of death with parts that are medically suitable for donation who could 
become a donor if the individual's family made an anatomical gift (section 9). The term does not include an individual who made a refusal as the 
refusal bars other persons from making an anatomical gift on that individual's behalf.
"Refusal" means a record created that expressly states intent to bar other persons from making an anatomical gift of an individual's body or part.
"Section 9 (a)" sets a prioritized list of classes of persons (power-of-attorney for health care, spouse, adult children, parents, adult siblings, adult 
grandchildren, grandparents, an adult who exhibited special care and concern for the decedent, persons who were acting as the guardians of the 
person of the decedent at the time of death, any other person having the authority to dispose of the decedent's body) who can make an anatomical 
gift of a decedent's body or part if the decedent was neither a donor nor had signed a refusal. The same list of classes of persons can be consulted 
for section 21(b) whether they would be willing to make a gift when the prospective donor is near death.
"Section 14(c)" When a hospital refers an individual at or near death to a procurement organization, the organization may conduct any reasonable 
examination necessary to ensure the medical suitability of a part that is or could be the subject of an anatomical gift for transplantation, therapy, 
research, or education from a donor or a prospective donor. During the examination period, measures necessary to ensure the medical suitability 
of the part may not be withdrawn unless the hospital or procurement organization knows that the individual expressed a contrary intent."
"Section 21(b)" If a prospective donor has a declaration or advance health-care directive and the terms of the declaration or directive and the 
express or implied terms of a potential anatomical gift are in conflict with regard to the administration of measures necessary to ensure the medical 
suitability of a part for transplantation or therapy, the prospective donor's attending physician and prospective donor shall confer to resolve the 
conflict. If the prospective donor is incapable of resolving the conflict, an agent acting under the prospective donor's declaration or directive, or, if 
none or the agent is not reasonably available, another person authorized by law other than this [Act] to make health-care decisions on behalf of the 
prospective donor, shall act for the donor to resolve the conflict. The conflict must be resolved as expeditiously as possible. Information relevant to 
the resolution of the conflict may be obtained from the appropriate procurement organization and any other person authorized to make an 
anatomical gift for the prospective donor under Section 9. Before resolution of the conflict, measures necessary to ensure the medical suitability of 
the part may not be withheld or withdrawn from the prospective donor if withholding or withdrawing the measures is not contraindicated by 
appropriate end-of-life care."Philosophy, Ethics, and Humanities in Medicine 2007, 2:19 http://www.peh-med.com/content/2/1/19
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life support systems for organ donation and appropriate
end-of-end life care for the dying patients, the amend-
ment is insufficient to protect patients and families from
potential violations of their rights to quality palliative
care. Section 21(b) (2007) requires the attending physi-
cian to balance contraindications for end-of-life care
against the need to preserve organs, which can only be
done after the OPO has completed medical evaluation to
determine if a patient can be considered a prospective
donor. Section 21(b) (2007) also includes the OPO as an
agent to assist with conflict resolution with regard to end-
of-life care, yet, the same agent has other undisclosed
incentives, i.e. maximizing organ procurement opportu-
nities [12]. There are no real safeguards to prevent the
OPO from either prolonging or manipulating end-of-life
decision making for prospective donors in order to obtain
donation consent.
The Revised UAGA (2006) requirement of life support sys-
tems for patients with clearly contrary end-of-life wishes
represents a radical departure from the PSDA (1991) and
original intent of advance health care directives. In fact, it
can be argued that the Revised UAGA (2006) intrudes into
patients' autonomy and infringes on their rights to self-
determination of medical care at the end-of-life.
Conclusion
Some states have already enacted the Revised UAGA
(2006) and a few of those have included amendments
while attempting to preserve the uniformity of the revised
Act (Figure 2). Other states have introduced the Revised
UAGA (2006) for legislation and remaining states are
likely to follow soon. The Revised UAGA (2006) increases
physicians' and hospitals' responsibilities to fulfill their
legal and moral obligations towards patients' rights for
self-determination of their medical care and quality of
palliation at the end-of-life. Therefore, it is imperative for
patients, families and physicians to become familiar with
the new US legislations about organ donation, so that the
document of gift and advance health care directives are
not in conflict and symbolize the commitment to
patient's autonomous decision-making at the end-of-life.
The premises underlying the subtle progression of the
Revised UAGA (2006) towards the presumption about
how to dispose of one's organs at or near death can pave
the way for an affirmative "duty to donate" to the detri-
ment of human liberty in a free society. Therefore, a broad
based societal discussion must be initiated to decide if the
Revised UAGA (2006) infringes on PSDA and the individ-
ual's right of autonomy. The discussion should also
address other ethical concerns raised by the Revised
UAGA (2006), including the moral stance on 1) the inter-
pretation of the refusal of life support systems as not
applicable to organ donation and 2) the disregarding of
the diversity of cultural beliefs about end-of-life in a plu-
ralistic society.
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